Transfusion‐related acute lung injury caused by an NB2 granulocyte‐ specific antibody in a patient with thrombotic thrombocytopenic purpura

HLA and granulocyte‐specific antibodies have been implicated in the production of transfusion‐related acute lung injury (TRALI). Reported here is a case that suggests that the patient's preexisting condition may play an important role in determining whether TRALI develops upon transfusion of blood products containing anti‐white cell (WBC) antibodies. A 29‐year‐old woman with thrombotic thrombocytopenic purpura (TTP) underwent an uneventful 1.5‐volume plasma exchange, which was followed by the transfusion of 2 red cell (RBC) units. At the end of the second RBC transfusion, the patient developed clinical signs and symptoms of noncardiogenic pulmonary edema. Serologic studies demonstrated that the serum from the second RBC donor had no HLA antibodies but did have a granulocyte‐specific antibody (anti‐NB2) that caused the agglutination of the recipient's granulocytes, which were NB2 positive. Serum from the donor of the first RBC unit and serum from the donors of units used in the exchange had no HLA or granulocyte‐ specific antibodies that reacted with the recipient's WBCs. Because the donor implicated in this reaction had a history of 21 blood donations, none of which had been associated with a transfusion reaction, we suggest that the patient's preexisting condition played a significant role in this episode of TRALI, owing to the granulocyte‐specific antibody. 1990 AABB